{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:46:25Z","timestamp":1790642785425,"version":"4.1.0"},"reference-count":66,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>Background\/Objectives: Pemphigus comprises a diverse group of disorders within the autoimmune bullous dermatoses (AIBDs) spectrum. Among these, pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are the most commonly encountered variants. Despite its rarity, this condition can pose a life-threatening risk. We aimed to assess clinical characteristics, comorbidities, medication, as well as the treatment of various types of pemphigus in pemphigus patients. Methods: We gathered data from 69 patients treated in the Department of Dermatology in the years 2016\u20132023. The investigation included sex, age at diagnosis, type of pemphigus, comorbidities and medications, presence of neoplasms and treatment of pemphigus, as well as enzyme-linked immunosorbent assay (ELISA) and direct immunofluorescence (DIF) results. The data were statistically analyzed with the p-value set at 0.05. Results: The study group comprised 69 patients, including 41 women and 28 men. The mean age at diagnosis was 56.89 years +\/\u2212 15.42 years. A total of 79.31% of the patients were diagnosed with PV and the following 26.09% with PF. The most common comorbidities were arterial hypertension, hypercholesterolemia, and diabetes mellitus. The dominant treatment regimen was the systemic use of glucocorticosteroids (GCSs; 90% and 94% of PV and PF patients, respectively). More than half of the patients received at least one GCS-sparing treatment, including dapsone and rituximab. We observed a significantly frequent presence of IgG deposits in DIF in patients with PF (p = 0.0217) and a subsequent correlation between the concurrent presence of IgG deposits in DIF and anti-DSG1 antibodies in ELISA testing (p = 0.0469). The combination of IgG, IgG1, IgG4, and C3 deposits was more often existent in PF patients (p = 0.0054) and the combination of IgG4 and C3 deposits in PV patients (p = 0.0339). We also found a positive correlation between the level of anti-DSG1 antibodies and the age at diagnosis (p = 0.0298). Conclusions: Patients with pemphigus are very often diagnosed with significant comorbidities and take diverse medication, which shows that the treatment of pemphigus should follow a multidisciplinary approach. Accurate analysis of the clinical condition of the patients, as well as the results of the ELISA panel or DIF, is crucial for a successful diagnostic and therapeutic process.<\/jats:p>","DOI":"10.3390\/antib13040103","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T05:55:45Z","timestamp":1734069345000},"page":"103","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Characteristics, Comorbidities, and Treatment in Patients with Pemphigus\u2014A Single-Center Retrospective Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7736-3219","authenticated-orcid":false,"given":"Natalia","family":"Welc","sequence":"first","affiliation":[{"name":"Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, 61701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5386-9090","authenticated-orcid":false,"given":"Sandra","family":"Wa\u017cniewicz","sequence":"additional","affiliation":[{"name":"Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, 61701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"G\u0142uszak","sequence":"additional","affiliation":[{"name":"Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, 61701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Spa\u0142ek","sequence":"additional","affiliation":[{"name":"Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, 61701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Seraszek-Jaros","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics and Computational Biology, Poznan University of Medical Sciences, 61701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-7475","authenticated-orcid":false,"given":"Magdalena","family":"Ja\u0142owska","sequence":"additional","affiliation":[{"name":"Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, 61701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4819-2051","authenticated-orcid":false,"given":"Marian","family":"Dmochowski","sequence":"additional","affiliation":[{"name":"Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, 61701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5114\/ada.2021.102857","article-title":"Clinical significance of umbilical region involvement in pemphigus vulgaris in a series of 81 ethnic Poles: A comparative analysis of the distribution of lesions in two infrequent locations","volume":"39","author":"Kaczmarek","year":"2022","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of Disease: Pemphigus and Bullous Pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5114\/ceji.2021.107028","article-title":"Conceptualization and validation of an innovative direct immunofluorescence technique utilizing fluorescein conjugate against IgG + IgG4 for routinely diagnosing autoimmune bullous dermatoses","volume":"46","author":"Kaczmarek","year":"2021","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ja\u0142owska, M., Gornowicz-Porowska, J., Bowszyc-Dmochowska, M., and Dmochowski, M. (2022). Sacral Dimple, Conjunctiva, and Nipple as Less Obvious Pemphigus Vulgaris Locations around Natural Body Orifices: A Report of Three Cases. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102855"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Dmochowski, M., Ja\u0142owska, M., and Bowszyc-Dmochowska, M. (2022). Issues occupying our minds: Nomenclature of autoimmune blistering diseases requires updating, pemphigus vulgaris propensity to affect areas adjacent to natural body orifices unifies seemingly diverse clinical features of this disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1103375"},{"key":"ref_6","first-page":"114","article-title":"Clinical, microscopic and molecular aspects of the hair follicle in autoimmune blistering dermatoses","volume":"8","year":"2006","journal-title":"Dermatol. Klin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: Overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2340\/00015555-2706","article-title":"Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality","volume":"97","author":"Kridin","year":"2017","journal-title":"Acta Derm. Venerol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-4632.2009.04345.x","article-title":"Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania","volume":"49","author":"Baican","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: Pemphigus and bullous pemphigoid","volume":"307","author":"Alpsoy","year":"2015","journal-title":"Arch. Dermatol. Res."},{"key":"ref_11","first-page":"181","article-title":"Epidemiology of Pemphigus in Turkey: One-year Prospective Study of 220 Cases","volume":"25","author":"Yayli","year":"2017","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1346-8138.12676","article-title":"Pemphigus in the Arab world","volume":"42","author":"Saleh","year":"2015","journal-title":"J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/1523-1747.ep12612836","article-title":"Comparative Epidemiology of Pemphigus in Tunisia and France: Unusual Incidence of Pemphigus Foliaceus in Young Tunisian Women","volume":"104","author":"Souissi","year":"1995","journal-title":"J. Investig. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.abd.2023.03.004","article-title":"Epidemiological and clinical study of cases of endemic pemphigus foliaceus and pemphigus vulgaris in a reference center in the state of Minas Gerais, Brazil","volume":"99","author":"Barcelos","year":"2024","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"ref_15","first-page":"524","article-title":"Epidemiologic Study of 20 Cases of Pemphigus at Hospital Cl\u00ednico Universitario Virgen de la Victoria de M\u00e1laga, Spain","volume":"101","year":"2010","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-4362.2001.01247.x","article-title":"The incidence of pemphigus in the southern region of Saudi Arabia","volume":"40","author":"Tallab","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/ijd.14078","article-title":"Incidence of pemphigus vulgaris and pemphigus foliaceus in North-East Poland (Podlaskie Province)\u2014A 15-year (2001\u20132015) bicentric retrospective study","volume":"57","author":"Serwin","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jid.2018.07.042","article-title":"Incidence and Mortality of Pemphigus in France","volume":"139","author":"Jelti","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Quintarelli, L., Coi, A., Maglie, R., Corr\u00e0, A., Mariotti, E.B., Aimo, C., di Calabria, V.R., Verdelli, A., Bianchi, B., and Del Bianco, E. (2022). Clinical Patterns, Survival, Comorbidities, and Treatment Regimens in 149 Patients With Pemphigus in Tuscany (Italy): A 12-Year Hospital-Based Study. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.895490"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hiermaier, M., Kugelmann, D., Radeva, M.Y., Didona, D., Ghoreschi, K., Farzan, S., Hertl, M., and Waschke, J. (2022). Pemphigus Foliaceus Autoantibodies Induce Redistribution Primarily of Extradesmosomal Desmoglein 1 in the Cell Membrane. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.882116"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5114\/ada.2023.127644","article-title":"Treatment-na\u00efve pemphigus patients showing IgG tissuedeposits have serum IgG antibodies against desmoglein 1detected more often than those against desmoglein 3:a monocentre laboratory experience","volume":"40","author":"Dmochowski","year":"2023","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2340\/00015555-2023","article-title":"Autoantibody Levels and Clinical Disease Severity in Patients with Pemphigus: Comparison of Aggregated Anti-desmoglein ELISA Values and Indirect Immunofluorescence Titres","volume":"95","author":"Weiss","year":"2015","journal-title":"Acta Derm. Venerol."},{"key":"ref_23","first-page":"122","article-title":"Bullous pemphigoid induced by escitalopram in a patient with depression","volume":"151","author":"Caccavale","year":"2016","journal-title":"G Ital. Dermatol. Venereol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107299","DOI":"10.1016\/j.intimp.2020.107299","article-title":"Drug-induced pemphigus: A systematic review of 170 patients","volume":"92","author":"Ghaedi","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Malik, A.M., Tupchong, S., Huang, S., Are, A., Hsu, S., and Motaparthi, K. (2021). An Updated Review of Pemphigus Diseases. Medicina, 57.","DOI":"10.3390\/medicina57101080"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12016-016-8532-0","article-title":"Medical Complications of Tattoos: A Comprehensive Review","volume":"50","author":"Islam","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e14989","DOI":"10.1111\/exd.14989","article-title":"An analysis of demographics, lifestyle factors and comorbidities of pemphigus in underrepresented groups: A cross-sectional study of the All of Us database","volume":"33","author":"Pathak","year":"2024","journal-title":"Exp. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/ced.12634","article-title":"Pemphigus and associated comorbidities: A cross-sectional study","volume":"40","author":"Heelan","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaad.2024.02.052","article-title":"Autoimmune blistering disorders and cardiovascular risks: A population-based cohort study","volume":"91","author":"Bonnesen","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/jop.13150","article-title":"The health-related quality of life and psychological profile in patients with oropharyngeal Pemphigus Vulgaris in complete clinical remission: A case-control study","volume":"50","author":"Calabria","year":"2021","journal-title":"J. Oral Pathol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hsu, Y.M., Fang, H.Y., Lin, C.L., and Shieh, S.H. (2020). The Risk of Depression in Patients with Pemphigus: A Nationwide Cohort Study in Taiwan. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17061983"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/ijstd.ijstd_14_24","article-title":"Pemphigus vulgaris in association with human immunodeficiency virus infection: A management dilemma","volume":"45","author":"Yadav","year":"2024","journal-title":"Indian J. Sex. Transm. Dis. AIDS"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/jid.2014.547","article-title":"Malignancies in Pemphigus and Pemphigoid Diseases","volume":"135","author":"Schulze","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jamadermatol.2017.6334","article-title":"Coexistent Solid Malignancies in Pemphigus: A Population-Based Study","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ced.14916","article-title":"Comorbid mental health issues in patients with pemphigus vulgaris and pemphigus foliaceus","volume":"47","author":"Matthews","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.advms.2016.07.002","article-title":"Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease\u2014Specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires","volume":"62","author":"Jakubowska","year":"2017","journal-title":"Adv. Med. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e056","DOI":"10.1097\/JW9.0000000000000056","article-title":"Burden of pemphigus vulgaris with a particular focus on women: A review","volume":"8","author":"Kianfar","year":"2022","journal-title":"Int. J. Womens Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Spa\u0142ek, M.M., Ja\u0142owska, M., Welc, N., Bowszyc-Dmochowska, M., and Dmochowski, M. (2024). Dapsone as a Current Option for the Treatment of Autoimmune Bullous Diseases with Autoimmunity to Non-Enzymes: A Retrospective Study from a Single Central European Referral Center. Medicina, 60.","DOI":"10.3390\/medicina60081324"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Spa\u0142ek, M.M., Ja\u0142owska, M., Bowszyc-Dmochowska, M., and Dmochowski, M. (2024). Rituximab in the Management of Autoimmune Bullous Diseases: A Treatment-Resistant Case Series from a Single Central European Referral Center. Medicina, 60.","DOI":"10.3390\/medicina60020270"},{"key":"ref_40","first-page":"51","article-title":"Comparative Analysis of Treatment Outcomes in Patients with Neuromyelitis Optica Spectrum Disorder Treated with Rituximab, Azathioprine, and Mycophenolate Mofetil: A Systematic Review and Meta-analysis","volume":"19","author":"Christy","year":"2022","journal-title":"Innov. Clin. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/bjd.18482","article-title":"Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect","volume":"182","author":"Chen","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/ijd.14143","article-title":"Retrospective analysis of a single-center clinical experience toward development of curative treatment of 123 pemphigus patients with a long-term follow-up: Efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion-protecting drugs","volume":"58","author":"Grando","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/exd.14829","article-title":"A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy","volume":"32","author":"Kianfar","year":"2023","journal-title":"Exp. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"106385","DOI":"10.1016\/j.intimp.2020.106385","article-title":"Rationale for including intravenous immunoglobulin in the multidrug protocol of curative treatment of pemphigus vulgaris and development of an assay predicting disease relapse","volume":"82","author":"Grando","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2340\/00015555-2611","article-title":"Mortality and Cause of Death in Patients with Pemphigus","volume":"97","author":"Kridin","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/jid.2011.249","article-title":"Incidence, mortality, and causes of death of patients with pemphigus in Taiwan: A nationwide population-based study","volume":"132","author":"Huang","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Vodo, D., Sarig, O., and Sprecher, E. (2018). The Genetics of Pemphigus Vulgaris. Front. Med., 5.","DOI":"10.3389\/fmed.2018.00226"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.humimm.2012.10.013","article-title":"Polymorphisms of HLA microsatellite marker in Tunisian pemphigus foliaceus","volume":"74","author":"Abida","year":"2013","journal-title":"Hum. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.autrev.2004.05.002","article-title":"The immunogenetics of pemphigus vulgaris","volume":"4","author":"Gazit","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1073\/pnas.88.11.5056","article-title":"Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1523-1747.1999.00626.x","article-title":"Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients","volume":"113","author":"Lombardi","year":"1999","journal-title":"J. Investig. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/iji.12052","article-title":"High susceptibility to pemphigus vulgaris due to HLA-DRB1*14:54 in the Slovak population","volume":"40","author":"Javor","year":"2013","journal-title":"Int. J. Immunogenet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.humimm.2005.09.003","article-title":"Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris","volume":"67","author":"Lee","year":"2006","journal-title":"Hum. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaut.2016.04.007","article-title":"Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent Southeastern Brazilian region","volume":"72","author":"Brochado","year":"2016","journal-title":"J. Autoimmun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2133.2009.09207.x","article-title":"Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: Anti-desmoglein 1 antibody-positive healthy subjects bear protective alleles","volume":"161","author":"Abida","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2310\/7750.2010.09061","article-title":"ICOS gene polymorphism may be associated with pemphigus","volume":"14","author":"Narbutt","year":"2010","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.humimm.2012.02.001","article-title":"Tumor necrosis factor-\u03b1 -308 G>A and interleukin-6 -174 G>C promoter polymorphisms and pemphigus","volume":"73","author":"Mosaad","year":"2012","journal-title":"Hum. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clindermatol.2016.05.021","article-title":"Pemphigus vulgaris and pemphigus foliaceus determined by CD86 and CTLA4 polymorphisms","volume":"35","author":"Tanasilovic","year":"2017","journal-title":"Clin. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/iji.12451","article-title":"Single-nucleotide polymorphisms associated with pemphigus vulgaris: Potent markers for better treatment and personalized medicine","volume":"47","author":"Mahmoudi","year":"2020","journal-title":"Int. J. Immunogenet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/12034754241266136","article-title":"Biomarkers in Pemphigus Vulgaris: A Systematic Review","volume":"28","author":"Geng","year":"2024","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/sj.jid.5700735","article-title":"Nuclear c-Myc: A molecular marker for early stage pemphigus vulgaris","volume":"127","author":"Williamson","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5114\/pdia.2017.71267","article-title":"Scalp involvement in pemphigus: A prognostic marker","volume":"35","author":"Konop","year":"2018","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1468-3083.2012.04509.x","article-title":"Is conjunctival mucous involvement a marker of severity in pemphigus vulgaris?","volume":"27","author":"Balica","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/jocd.13719","article-title":"Serum levels of soluble PD1 in pemphigus vulgaris: A useful marker for disease severity","volume":"20","author":"Zeid","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0003319717718329","article-title":"Mean Platelet Volume in Pemphigus Vulgaris","volume":"69","author":"Kridin","year":"2018","journal-title":"Angiology"}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/13\/4\/103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:54:16Z","timestamp":1760115256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/13\/4\/103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["antib13040103"],"URL":"https:\/\/doi.org\/10.3390\/antib13040103","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}